JONES CECILIA (Chief Financial Officer) sold 5.4% of their position (3.14K shares) of AGIOS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $109.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2026ACC: 0001439222-26-000063
Officer· Chief Financial Officer
Since Mar 2026
-3.14K
Net shares
Net seller
$109.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.50K acquired · 11.64K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
+8.50K
Price / share
—
Trade value
—
% of position
17.1%
4/2/2026
49.64K→58.14K
Common stock
Direct
Shares
−3.14K
Price / share
$34.71
Trade value
$109.02K
% of position
5.4%
4/2/2026
58.14K→55K
Total
Net shares
+5.36K
Net value
-$109.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 4/2/2026 | M · Option Exercise | +8.50K | — | — | 17.1% | 49.64K | 58.14K |
| Common stock Direct | 4/2/2026 | S · Sale | −3.14K | $34.71 | $109.02K | 5.4% | 58.14K | 55K |
| Total | +5.36K | -$109.02K | ||||||
Derivative Transactions1
Performance share units
Direct
Converts to
Common stock
8.50K shares
Shares
−8.50K
Strike price
Held after
8.50K
Exercisable
—
4/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance share units Direct | Common stock8.50K shares | 4/2/2026 | M · Option Exercise | −8.50K | — | 8.50K |